Donald L. Hagan LLC’s Novo Nordisk NVO Stock Holding History

Donald L. Hagan LLC’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-400	Closed	-$11K	–	233
2015 Q3	$11K	Buy	+400	New	+$11.3K	0.01%	274

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Donald L. Hagan LLC's NVO Position: Q4 2015 in Review

Donald L. Hagan LLC sold out of Novo Nordisk (NVO) in Q4 2015, closing a stake of 400 shares — an estimated $11K sold.

Donald L. Hagan LLC first reported a position in NVO in Q3 2015 and held it in 1 quarter. The position peaked at $11K in Q3 2015. 548 funds tracked by Wall St. Rank hold NVO as of Q4 2015.

Donald L. Hagan LLC reported no remaining Novo Nordisk position as of Q4 2015 after selling out during the quarter.
Donald L. Hagan LLC sold 400 Novo Nordisk shares in Q4 2015, an estimated $11K.
Donald L. Hagan LLC first reported a position in Novo Nordisk in Q3 2015 and held it in 1 quarter.
Donald L. Hagan LLC's Novo Nordisk position peaked at $11K in Q3 2015.
548 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2015.

Based on Donald L. Hagan LLC's 13F filing for Q4 2015, filed 20 Jan 2016.